3-iodobenzylguanidine has been researched along with Memory Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inaoka, T; Kishi, M; Sakakibara, R; Tateno, F; Terada, H; Tsuyusaki, Y | 1 |
| Abe, K; Chikamori, T; Hanyu, H; Hida, S; Hirao, K; Iwamoto, T; Koizumi, K; Sakurai, H; Shimizu, S; Yamashina, A | 1 |
1 review(s) available for 3-iodobenzylguanidine and Memory Disorders
| Article | Year |
|---|---|
MIBG myocardial scintigraphy in pre-motor Parkinson's disease: a review.
Topics: 3-Iodobenzylguanidine; Animals; Constipation; Humans; Hypotension, Orthostatic; Memory Disorders; Myocardial Perfusion Imaging; Parkinson Disease; Radiopharmaceuticals; REM Sleep Behavior Disorder | 2014 |
1 other study(ies) available for 3-iodobenzylguanidine and Memory Disorders
| Article | Year |
|---|---|
The role of 123I-metaiodobenzylguanidine myocardial scintigraphy in the diagnosis of Lewy body disease in patients with dementia in a memory clinic.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Brain; Dementia; Diagnosis, Differential; Female; Humans; Lewy Body Disease; Male; Memory Disorders; Myocardium; Nerve Degeneration; Neuropsychological Tests; Radiopharmaceuticals; Severity of Illness Index; Tomography, Emission-Computed | 2006 |